Summary slide.png (118.29 kB)
Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study
figure
posted on 2020-10-22, 12:31 authored by Preeya J. Patel, Christian Weidenfeller, Andrew P. Jones, Jens Nilsson, Jay HsuArticle full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
